Abstract 298P
Background
It was still controversial regarding the postoperative preservation of pulmonary function after segmentectomy over lobectomy. In particular, resection for three or more segment was associated with more profound decreased in lung function. The purpose of this study was to investigate the effect of left upper division (LUD) segmentectomy on postoperative pulmonary function and lung volume comparison of left upper lobectomy among clinical stage IA non-small cell lung cancer (NSCLC).
Methods
Among clinical stage IA NSCLC patients who underwent LUD segmentectomy or left upper lobectomy between 2013 and 2018, postoperative changes in pulmonary function, 3-dimensional computed tomography (CT) volumetry and the percentage of low attenuation areas (% LAAs) were retrospectively reviewed according to surgical procedure. Changes in pulmonary function by groups were compared using linear mixed model with linear spline, random intercepts and slope.
Results
A total of 264 patient were identified, the study group consisted with 85 LUD segmentectomy (32.2%) and 179 left lobectomy (67.8%). In the adjusted model, no significant difference was observed among changes in pulmonary function by surgical procedure. In terms of lung volume, postoperative volume in contralateral lung and LLL was increased in both groups, it is more likely to have greater increase in LLL volume in lobectomy group (333.4 vs. 451.6 ml, p<0.001) than those in segmentectomy group. After surgery, the % LAA of left lung and LLL in the lobectomy group significantly increased compared to those in the segmentectomy group (0.37 vs. 1.31, p=0.002; 0.53 vs. 1.82, p<0.001), while change of % LAA of right lung was not significantly differ by surgical procedure. In the linear regression model, changes in lung volume and % LAA in left lung and LLL was significantly associated with type of surgery.
Conclusions
Postoperative changes in pulmonary function after LUD segmentectomy and left upper lobectomy was not significantly different. However, segmentectomy was significantly associated with less volume expansion and less increased % LAA compared with those in lobectomy.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
291P - Assessment of nutritional status in cancer patients using patient generated subjective global assessment screening tool
Presenter: Anuj K. C.
Session: Poster viewing 04
293P - Generic dabigatran for cancer-associated venous thromboembolism: Real-world data
Presenter: Fen Saj
Session: Poster viewing 04
294P - Cross-sectional analysis on cancer-related distress, belief in alternative medicine among cancer patients and attendants visiting a tertiary care center in Northern India
Presenter: Amit Sehrawat
Session: Poster viewing 04
296P - Osimertinib as adjuvant therapy in patients (pts) with resected EGFR-mutated (EGFRm) stage IB-IIIA non-small cell lung cancer (NSCLC): Updated results from ADAURA
Presenter: Yi-Long Wu
Session: Poster viewing 04
297P - Transbronchial microwave ablation of early lung cancers and lung oligometastases: Mid-term results
Presenter: Joyce Chan
Session: Poster viewing 04
299P - Furmonertinib as adjuvant therapy in EGFR-mutated non-small cell lung cancer following radical lung cancer surgery
Presenter: Qingyi Zhang
Session: Poster viewing 04
300P - Real-world efficacy and safety of anlotinib in combination with PD-1/PD-L1 inhibitors as first-line or second-line treatment in advanced non-small cell lung cancer
Presenter: Xin Shang
Session: Poster viewing 04
301P - Oxygen desaturation during 6-min walk test: Implications for postoperative complications in non-small cell lung cancer patients with impaired lung function
Presenter: Hye Yun Park
Session: Poster viewing 04
302P - Treatment patterns in resectable early-stage NSCLC in Taiwan: Subgroup analysis of a global real-world study
Presenter: Jin-Yuan Shih
Session: Poster viewing 04